Ethnic disparities in diabetic complications in an insured population

被引:701
作者
Karter, AJ [1 ]
Ferrara, A [1 ]
Liu, JY [1 ]
Moffet, HH [1 ]
Ackerson, LM [1 ]
Selby, JV [1 ]
机构
[1] Kaiser Permanente, Div Res, Oakland, CA 94612 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2002年 / 287卷 / 19期
关键词
D O I
10.1001/jama.287.19.2519
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Higher rates of microvascular complications have been reported for minorities. Disparate access to quality health care is a common explanation for ethnic disparities in diabetic complication rates in the US population. Examining an ethnically diverse population with uniform health care coverage may be useful. Objective To assess ethnic disparities in the incidence of diabetic complications within a nonprofit prepaid health care organization. Design and Setting Longitudinal observational study conducted January 1, 1995, through December 31, 1998, at Kaiser Permanente Medical Care Program in northern California. Participants A total of 62432 diabetic patients including Asians (12%), blacks (14%), Latinos (10%), and whites (64%). Main Outcome Measures Incident myocardial infarction (MI), stroke, congestive heart failure (CHF), and nontraumatic lower extremity amputation (LEA), defined by primary hospitalization discharge diagnosis, procedures, or underlying cause of death; and end-stage renal disease (ESRD), defined as renal insufficiency requiring renal replacement therapy or transplantation for survival or by underlying cause of death. Results Patterns of ethnic differences were not consistent across complications and frequently persisted despite adjustment for a wide range of demographic, socioeconomic, behavioral, and clinical factors. Adjusted hazard ratios (relative to that of whites) were 0.56, 0.68, and 0.68 for blacks, Asians, and Latinos, respectively (P<.001), for MI; 0.76 and 0.72 for Asians and Latinos, respectively (P<.01), for stroke; 0.70 and 0.61 for Asians and Latinos, respectively (P<.01), for CHF; 0.40 for Asians (P<.001) for LEA and 2.03, 1.85, and 1.46 for blacks, Asians, and Latinos, respectively (P<.01), for ESRD. There were no statistically significant black-white differences for stroke, CHF, or LEA and no Latino-white differences for LEA. Conclusions This study confirms previous reports of elevated incidence of ESRD among ethnic minorities, despite uniform medical care coverage, and provides new evidence that rates of other complications are similar or lower relative to those of whites. The persistence of ethnic disparities after adjustment suggests a possible genetic origin, the contribution of unmeasured environmental factors, or a combination of these factors.
引用
收藏
页码:2519 / 2527
页数:9
相关论文
共 75 条
  • [51] EXCESS INCIDENCE OF TREATMENT OF END-STAGE RENAL-DISEASE IN MEXICAN-AMERICANS
    PUGH, JA
    STERN, MP
    HAFFNER, SM
    EIFLER, CW
    ZAPATA, M
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1988, 127 (01) : 135 - 144
  • [52] Pugh Jacqueline A., 1992, Journal of Diabetes and its Complications, V6, P236, DOI 10.1016/1056-8727(92)90058-S
  • [53] RISK-FACTORS FOR AMPUTATION IN PATIENTS WITH DIABETES-MELLITUS - A CASE-CONTROL STUDY
    REIBER, GE
    PECORARO, RE
    KOEPSELL, TD
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 117 (02) : 97 - 105
  • [54] PREVALENCE OF CORONARY HEART-DISEASE IN SUBJECTS WITH NORMAL AND IMPAIRED GLUCOSE-TOLERANCE AND NON-INSULIN-DEPENDENT DIABETES-MELLITUS IN A BIETHNIC COLORADO POPULATION - THE SAN-LUIS-VALLEY DIABETES STUDY
    REWERS, M
    SHETTERLY, SM
    BAXTER, J
    MARSHALL, JA
    HAMMAN, RF
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 135 (12) : 1321 - 1330
  • [55] RISCH N, IN PRESS GENOME BIOL
  • [56] Excess type 2 diabetes in African-American women and men aged 40-74 and socioeconomic status: evidence from the Third National Health and Nutrition Examination Survey
    Robbins, JM
    Vaccarino, V
    Zhang, HP
    Kasl, SV
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2000, 54 (11) : 839 - 845
  • [57] ROSEN AB, 2002, SOC GEN INT MED MAY
  • [58] RACIAL-DIFFERENCES IN THE INCIDENCE OF TREATMENT FOR END-STAGE RENAL-DISEASE
    ROSTAND, SG
    KIRK, KA
    RUTSKY, EA
    PATE, BA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (21) : 1276 - 1279
  • [59] On the evaluation of drug benefits policy changes with longitudinal claims data: the policy maker's versus the clinician's perspective
    Schneeweiss, S
    Maclure, M
    Walker, AM
    Grootendorst, P
    Soumerai, SB
    [J]. HEALTH POLICY, 2001, 55 (02) : 97 - 109
  • [60] Racial disparities in the quality of care for enrollees in medicare managed care
    Schneider, EC
    Zaslavsky, AM
    Epstein, AM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (10): : 1288 - 1294